Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histologically-confirmed Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04180215
What this trial is testing

A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

Who this might be right for
HPV-Related Squamous Cell Carcinoma
Hookipa Biotech GmbH 198
Testing effectiveness (Phase 2)Study completedNCT00386815
What this trial is testing

Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Eli Lilly and Company 20
Not applicableActive Not RecruitingNCT00860652
What this trial is testing

Radiotherapy - Adjuvant Versus Early Salvage

Who this might be right for
Prostate Cancer
Trans Tasman Radiation Oncology Group 333
Early research (Phase 1)Study completedNCT01795586
What this trial is testing

A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast Patients

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 19
Not applicableStudy completedNCT02217358
What this trial is testing

Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions

Who this might be right for
Chronic Inflammation of HypopharynxHoarsenessMacroscopic Laryngeal Lesions+5 more
University Hospital Ostrava 150
Testing effectiveness (Phase 2)Study completedNCT05337137
What this trial is testing

Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
Bristol-Myers Squibb 83
Testing effectiveness (Phase 2)Study completedNCT01631903
What this trial is testing

Extension of Study ZPV-200

Who this might be right for
Uterine Fibroids
Repros Therapeutics Inc. 48
Early research (Phase 1)Study completedNCT00744562
What this trial is testing

Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors

Who this might be right for
Solid Tumors
OncoMed Pharmaceuticals, Inc. 42
Testing effectiveness (Phase 2)Looking for participantsNCT07104149
What this trial is testing

Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer

Who this might be right for
Female, Age ≥ 18 Years OldNo Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/ImmunotherapyECOG Score of 0-1+6 more
The First Affiliated Hospital of Zhengzhou University 29
Testing effectiveness (Phase 2)Looking for participantsNCT05841550
What this trial is testing

The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple Myeloma
Oslo University Hospital 20
Not applicableStudy completedNCT03146013
What this trial is testing

Dual Algorithm Post Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 100
Not applicableStudy completedNCT04624568
What this trial is testing

Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance

Who this might be right for
Squamous Intraepithelial Lesions of the CervixHuman Papilloma Virus InfectionCervix Lesion
Centre Hospitalier Régional d'Orléans 81
Early research (Phase 1)Active Not RecruitingNCT07749703
What this trial is testing

A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors

Who this might be right for
Histologically or Cytologically Confirmed Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd. 346
Early research (Phase 1)Study completedNCT01256853
What this trial is testing

Modified Vaccinia Ankara (MVA) Vaccine Study

Who this might be right for
Nasopharyngeal NeoplasmsEpstein-Barr Virus Infections
Chinese University of Hong Kong 18
Large-scale testing (Phase 3)Ended earlyNCT02174445
What this trial is testing

An Open-label, Randomised Multicenter Phase 3b Study to Determine the Confirmed Rate of Molecular Response ≥ 4 Log (MR4) at Two Years

Who this might be right for
Chronic Myeloid Leukemia
Prof. Dr. Nikolas von Bubnoff 14
Early research (Phase 1)Study completedNCT01277146
What this trial is testing

A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors

Who this might be right for
Solid Tumors
OncoMed Pharmaceuticals, Inc. 42
Not applicableLooking for participantsNCT07173868
What this trial is testing

FDG PET-CT in Advanced Breast Cancer

Who this might be right for
Histologically Confirmed Metastatic or Locally Advanced Breast Cancer With no Radical Topical Treatment AvailableIf There is Liver Metastasis, Which the Researcher Believes Will be Difficult to Evaluate the Response Accurately With Bone Metastasis or CT
Samsung Medical Center 100
Early research (Phase 1)Study completedNCT00674791
What this trial is testing

Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of Disease

Who this might be right for
Breast Cancer
Duke University 13
Early research (Phase 1)Study completedNCT01165905
What this trial is testing

Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors

Who this might be right for
Solid Tumor
Traws Pharma, Inc. 10
Early research (Phase 1)Study completedNCT02036281
What this trial is testing

Substance P-Saporin in Terminal Cancer Patients With Intractable Pain

Who this might be right for
Terminally IllHistologically-confirmed Advanced CancerPain, Intractable
University of Texas Southwestern Medical Center 23
Next Page